The innovation stem-cell use for curing diabetes, supported by research and development on the part of Chulalongkorn University, Samitivej Srinakarin Hospital and Bangkok Hospital.

Stem-cell innovation has become popular worldwide, and this is the first time that the Kingdom has developed its own medical inventions to catch up with the US and European countries, said NIA director Supachai Lorlowhakarn.

Teerachai Chantarojanasiri, director of Samitivej Srinakarin Hospital, said stem cells could be used as spare parts for the human body.

He said about 40,000 diabetes patients each year sacrificed their legs to save their lives, an operation costing more than Bt1 million per person. Stem cells are another alternative for the cure of diabetes at a cost of Bt200,000 to Bt300,000.

He said stem cells would reduce the annual cost of diabetes to the nation of Bt42 billion.

Supachai said this was the second year the "Top 10 Innovative Business" event had been held, reflecting the NIA's target of stimulating innovation in Thailand.

The winners were selected from 170 projects with NIA support over the past three years.

Supachai said the NIA had supported 85 projects with a budget of Bt76.7 million this year, which created an investment value of Bt3.13 billion.

Supachai said the firms given the award had to be a new type of business, providing advanced technology.

They must have high potential to compete in the world market and encourage the trend of proactive innovation in Thailand.

Finally, he said they must also have intellectual-property protection together with good management.

Chalida  Ekvitthayavechnukul  

The Nation